scispace - formally typeset
S

Seyed Mehdi Sadat

Researcher at Pasteur Institute of Iran

Publications -  88
Citations -  1036

Seyed Mehdi Sadat is an academic researcher from Pasteur Institute of Iran. The author has contributed to research in topics: Immunogenicity & Antigen. The author has an hindex of 13, co-authored 88 publications receiving 852 citations. Previous affiliations of Seyed Mehdi Sadat include Pasteur Institute & Islamic Azad University.

Papers
More filters
Journal ArticleDOI

Polymeric nanoparticles: Potent vectors for vaccine delivery targeting cancer and infectious diseases

TL;DR: This review describes polymeric carriers especially PLGA, chitosan, and PEI as vaccine delivery systems as well as natural polymers such as polysaccharides and synthetic polymers have demonstrated great potential to form vaccine nanoparticles.
Journal ArticleDOI

HCV core protein immunization with Montanide/CpG elicits strong Th1/Th2 and long-lived CTL responses

TL;DR: Mice immunized with M720(+CpG) developed the highest HCVcp-specific titers of total IgG, IgG1, 2a, 2b, and that of IFN-gamma and IL-4 cytokines compared to all other groups, suggesting HCVCP formulated in M720 could induce balanced and strong Th1/Th2 responses with long-lived CD4(-)CD8(+) CTLs.
Journal ArticleDOI

Inhibition of HIV and HSV infection by vaginal lactobacilli in vitro and in vivo.

TL;DR: Current data indicates that lactobacilli supernatant encompasses components with neutralizing activity against HIV and HSV and it would be a determinant factor for viral diseases transmission and promising lead for anti-viral probiotic design.
Journal ArticleDOI

Combination of cell penetrating peptides and heterologous DNA prime/protein boost strategy enhances immune responses against HIV-1 Nef antigen in BALB/c mouse model

TL;DR: Findings showed that the use of Tat (PTD)-Nef antigen in prime-boost strategy along with Gp96 adjuvant and Cady-2 CPP may have practical implications for developing HIV-1 vaccine in large animal model.
Journal ArticleDOI

Application of Outer Membrane Vesicle of Neisseria meningitidis Serogroup B as a New Adjuvant to Induce Strongly Th1-Oriented Responses Against HIV-1

TL;DR: HIV-1 VLPs combined with N. meningitidis B OMVs seem to be a promising approach in vaccine development against HIV-1, and results of cytokine and ELISpot assays showed the capability of VLP+OMV immunogen for effective induction of IFN-gamma; and IL4 secreting cells and suggested the promotion of Th1-oriented response that was evidenced with the increasedIFN-γ/IL4 secretion ratio.